scholarly journals Treatment of Anorexia Nervosa—New Evidence-Based Guidelines

2019 ◽  
Vol 8 (2) ◽  
pp. 153 ◽  
Author(s):  
Gaby Resmark ◽  
Stephan Herpertz ◽  
Beate Herpertz-Dahlmann ◽  
Almut Zeeck

Anorexia nervosa is the most severe eating disorder; it has a protracted course of illness and the highest mortality rate among all psychiatric illnesses. It is characterised by a restriction of energy intake followed by substantial weight loss, which can culminate in cachexia and related medical consequences. Anorexia nervosa is associated with high personal and economic costs for sufferers, their relatives and society. Evidence-based practice guidelines aim to support all groups involved in the care of patients with anorexia nervosa by providing them with scientifically sound recommendations regarding diagnosis and treatment. The German S3-guideline for eating disorders has been recently revised. In this paper, the new guideline is presented and changes, in comparison with the original guideline published in 2011, are discussed. Further, the German guideline is compared to current international evidence-based guidelines for eating disorders. Many of the treatment recommendations made in the revised German guideline are consistent with existing international treatment guidelines. Although the available evidence has significantly improved in quality and amount since the original German guideline publication in 2011, further research investigating eating disorders in general, and specifically anorexia nervosa, is still needed.

2021 ◽  
Vol 1 (11) ◽  
Author(s):  
Kylie Tingley ◽  
Melissa Walter

No relevant literature was identified regarding the comparative clinical effectiveness of cardiac monitoring devices for adolescents with eating disorders in inpatient settings. No evidence-based guidelines were identified regarding cardiac monitoring for adolescents with eating disorders in inpatient settings.


2020 ◽  
Vol 59 (2) ◽  
pp. 456
Author(s):  
Krista L. Harrison ◽  
Christine S. Ritchie ◽  
Abraham A. Brody ◽  
Sarah B. Garrett ◽  
Alissa Bernstein ◽  
...  

Author(s):  
Michael J. Devlin ◽  
Joanna E. Steinglass

This chapter discusses feeding and eating disorders, which are characterized by disturbed eating behavior and excessive concern about body weight and shape. There is substantial comorbidity of anorexia nervosa and bulimia nervosa. Many patients with bulimia nervosa have other mental health problems related to impulse control as well, such as substance use disorders. Patients with binge-eating disorder experience periods of consumption of objectively large amounts of food accompanied by a feeling of loss of control. Anorexia nervosa is one of the most lethal psychiatric illnesses, as it is associated with mortality rates as high as 5% per decade of illness.


2012 ◽  
Vol 26 (3) ◽  
pp. 270-279 ◽  
Author(s):  
Divyamani Srinivasan ◽  
Bree Watzak

Venous thromboembolism (VTE) encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). Each year, VTE affects about 300 000 to 600 000 people in the United States, and death is the first manifestation in one-fourth of this population.1{Beckman, 2010 #79} Moreover, approximately 10% of the US population has genetic factors that increase their risk for developing thrombosis.1 In addition to inherited disorders, factors that contribute to VTE include prolonged immobilization, trauma, surgery, cancer, and critically ill patients.2 Routine assessment and prophylaxis are recommended in these groups to avoid DVT-related complications.2 Anticoagulants are the mainstay of drugs used in DVT/PE prevention and treatment. Despite the availability of evidence-based guidelines for anticoagulant therapy, there is suboptimal implementation of DVT prophylaxis in hospitalized patients.3 All anticoagulants are “high-alert” drugs, and judicious use is mandatory to prevent bleeding complications.4 This review discusses treatment guidelines, monitoring, side effects, and reversal agents available for some anticoagulant drugs approved for VTE. Dissemination of the knowledge via pharmacy education programs significantly improves the adherence to VTE prophylaxis.5 Understanding the clinical aspects of anticoagulant dispensing as presented in this review is hoped to facilitate implementation of the theoretical knowledge as well as evidence-based guidelines in order to maximize patient benefit.


2020 ◽  
Author(s):  
Sean O'Dell ◽  
Matthew J. Gormley ◽  
Victoria Schlieder ◽  
Tracey Klinger ◽  
Kathy DeHart ◽  
...  

Abstract Background and Objectives: Despite efficacious treatments and evidence-based guidelines, youth coping with attention deficit hyperactivity disorder (ADHD) receive suboptimal care. Primary care clinicians (PCCs) are frontline providers of ADHD care; however, little is known about PCC perspectives regarding this care gap and how to effectively address it within health systems. We investigated PCC perspectives on determinants of pediatric ADHD care and considerations for improving adherence to evidence-based guidelines. Methods: Semi-structured qualitative interviews were conducted with 26 PCCs representing clinics within a health system on improving adherence to treatment guidelines for pediatric ADHD. Interview guides were based on the Pragmatic Robust Implementation and Sustainability Model (PRISM) to elicit PCC views regarding determinants of current practices and suggestions to guide improvement efforts. We used thematic analysis to identify patterns of responding that were common across participants.Results: We identified 12 themes categorized into two broad domains: Status Quo of Pediatric ADHD Care and Supporting and Constraining Factors for Improvement Initiatives. PCCs identified several internal and external contextual factors as determinants of current practices. Of note, PCCs reported they face challenges at multiple steps in the care process, including mental health stigma, coordinating care across settings, clinical productivity pressures, access to behavioral health care, and insurance mandates regarding medications. PCCs recommended efficient continuing education trainings accompanied by improvements to the electronic health record to include validated screening tools and documentation templates.Conclusions: Future research triangulating these findings may help to more efficiently improve the quality of pediatric ADHD care in health systems.


Author(s):  
Julian Baudinet ◽  
Lisa Dawson ◽  
Sloane Madden ◽  
Phillipa Hay

Chapter 10 discusses the prevalence and manifestation of childhood and adolescent eating disorders focusing on Anorexia Nervosa (AN), due to its prevalence. Implementation of maladaptive emotion regulation strategies, with a reduced ability to label and describe emotions leads to the development and propagation of AN. Family based treatments have been widely recognized, as the leading intervention for adolescents with AN, with efficacy rates from 20% to 60%. However, this chapter focuses on a novel approach to AN treatment, centered on emotion regulation in its management, as this may improve treatment outcomes. Programs include: Maudsley Model of Anorexia Nervosa Treatment for Adults and Emotion Acceptance Behavior Therapy, in addition to the modification or adaption of existing, evidence based treatments, such as Radically-Open DBT, although many programs require empirical validation in adolescent samples.


Author(s):  
Jenna L. Schleien ◽  
Gina Dimitropoulos ◽  
Katharine L. Loeb ◽  
Daniel Le Grange

It is well recognized that diagnostic assessments and evidence-based treatment approaches developed for anorexia nervosa (AN) or bulimia nervosa (BN) do not apply as well to atypical and complex eating disorders. This chapter provides a description of the evolution of diagnostic criteria for eating disorder presentations that do not fall under the categories of AN and BN. The chapter begins with an overview of atypical and complex comorbid eating disorders, including historical development, diagnostic criteria, and symptom presentation. Following this conceptual overview, the chapter discusses the challenges of applying results from randomized clinical trials for AN or BN to individuals affected by atypical eating disorders or comorbid diagnoses such as anxiety and substance abuse. The chapter concludes by outlining some possible solutions to the conundrum of identifying effective solutions for individuals with atypical and complex comorbid eating disorders.


Sign in / Sign up

Export Citation Format

Share Document